<DOC>
	<DOCNO>NCT00239512</DOCNO>
	<brief_summary>Patent ductus arteriosus ( PDA ) one common complication premature infant . Successful pharmacological closure PDA indomethacin first report 1976 . Since indomethacin treatment become standard prophylactic treatment clinically significant PDA premature infant . Clinically high incidence complication associate indomethacin treatment , include hypoglycemia , necrotizing enterocolitis , GI bleeding , extension IVH . More recently , ibuprofen show effective closure patent ductus arteriosus premature infant without reduce mesenteric , renal , cerebral blood flow.Ibuprofen show close ductus animal without reduce cerebral , intestinal renal blood flow . Furthermore , ibuprofen enhance cerebral blood-flow autoregulation neuroprotective effect . In recent year , strategy PDA treatment ELBW infant essentially early targeted indomethacine treatment depend echocardiographic shunt flow pattern PDA . ( Arch Dis Child 1997 ; 77 : F36-F40 . Acta Paediatr Tw 1998 ; 39:33-7. Arch Dis Child 1999 ; 79 : F197-F200 . ) By regimen , infant eligible study birth weight less 1000 gm PDA without structured cardiac anomaly confirm echocardiography shortly birth ( close possible to12 hour ) . After parental informed consent obtain , infant randomly assign two group base double-blined design . INDO group receive echocardiographic assessment interval 12-24 hour clinically necessary , PDA pulsatile grow flow pattern , indomethacin give ; PDA flow pattern grow pulsatile pattern , treatment give . The subsequent dose indomethacin accord echocardiographic flow pattern interval 24 hour last dose . When indomethacin fail close first course , second course another 3 dos indomethacin ibuprofen give . In spite infant INDO group IBUO group , PDA fail close 2 course treatment , surgical ligation PDA would consider accord infant â€™ clinical condition . Our historical data show incidence complication 30 % . Permitting 5 % chance type I error 20 % type II error absolute reduction incidence 20 % , 30 infant group need detect difference . Primary outcome assessment closure rate PDA incidence death pulmonary hemorrhage . Secondary outcome IVH PVL , NEC , oliguria CLD . We expect , use treatment regimen , high PDA closure rate achieve survival premature infant may increase .</brief_summary>
	<brief_title>New Management Strategy PDA VLBW Preterm Infants</brief_title>
	<detailed_description>Patent ductus arteriosus ( PDA ) continue one common problem premature infant . Delayed closure PDA impair renal function oligouria.The complication correlate serum concentration indomethacin , safe therapeutic range serum concentration indomethacin narrow . Therefore , could try another way Ibuprofen close PDA , prevent complication indomethacin . We expect , use treatment regimen accord echocardiographic flow pattern , high PDA closure rate achieve survival premature infant may increase .</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Ductus Arteriosus , Patent</mesh_term>
	<mesh_term>Indomethacin</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>1 . Premature infant birth weight &lt; 1000 gm 2 . Premature infant RDS require IMV 3 . Echocardiographic evidence PDA within 12 hour birth Presence prenatal infection , congenital anomalities lethal cardiopulmonary status</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>7 Days</maximum_age>
	<verification_date>June 2006</verification_date>
	<keyword>PDA</keyword>
	<keyword>VLBW infant</keyword>
	<keyword>Indomethacin</keyword>
	<keyword>Ibuprofen</keyword>
</DOC>